CyQUANT™ Cell Lysis Buffer (20X), 50 mL - Citations

CyQUANT™ Cell Lysis Buffer (20X), 50 mL - Citations

View additional product information for CyQUANT™ Cell Proliferation Assays - Citations (C35012, C35013, C35011, C7027, C7026, C35006, C35007)

Showing 5 product Citations

Citations & References
Abstract
Detection of residual donor leucocytes in leucoreduced red blood cell components using a fluorescence microplate assay.
AuthorsGilbert RL, Rider JR, Turton JR, Pamphilon DH
JournalJ Immunol Methods
PubMed ID12609529
'In November 1999, universal leucoreduction of blood components was introduced in the UK to minimise the risk of variant Creutzfeldt-Jakob Disease (vCJD) transmission by blood transfusion. The UK specifications for leucodepletion processes state that 99% of leucodepleted components should contain < 5 x 10(6) leucocytes/unit, within 95% confidence limits. However, ... More
AMPK and Endothelial Nitric Oxide Synthase Signaling Regulates K-Ras Plasma Membrane Interactions via Cyclic GMP-Dependent Protein Kinase 2.
Authors
JournalMol Cell Biol
PubMed ID27697864
Two novel atypical PKC inhibitors; ACPD and DNDA effectively mitigate cell proliferation and epithelial to mesenchymal transition of metastatic melanoma while inducing apoptosis.
Authors
JournalInt J Oncol
PubMed ID29048609
Phosphatidylethanolamines modified by γ-ketoaldehyde (γKA) induce endoplasmic reticulum stress and endothelial activation.
Authors
JournalJ Biol Chem
PubMed ID21454544
Oncogenic PKC-ι activates Vimentin during epithelial-mesenchymal transition in melanoma; a study based on PKC-ι and PKC-ζ specific inhibitors.
Authors
JournalCell Adh Migr
PubMed ID29781749